Decreased intracellular pH induced by cariporide differentially contributes to human umbilical cord-derived mesenchymal stem cells differentiation

Cellular Physiology and Biochemistry

Volumn 33, Issue 1, 2014, Pages 185-194

  Gao, Wei ^a,b   Zhang, Hairui ^a   Chang, Guoqiang ^a   Xie, Zhenqing ^a   Wang, Hanyu ^a   Ma, Li ^a   Han, Zhongchao ^a   Li, Qinghua ^a   Pang, Tianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Adipogenic differentiation catenin; Mesenchymal stem cells; Osteogenic differentiation

Indexed keywords

BETA CATENIN; CARIPORIDE; SODIUM PROTON EXCHANGE PROTEIN 1; FLUORESCENT DYE; CATION TRANSPORT PROTEIN; GUANIDINE DERIVATIVE; SLC9A1 PROTEIN, HUMAN; SMALL INTERFERING RNA; SODIUM PROTON EXCHANGE PROTEIN; SULFONE;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FUNCTION; CELL PH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UMBILICAL CORD; ADIPOCYTE; ALKALINIZATION; CELL GROWTH; DRUG CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL; K562 CELL LINE; MTT ASSAY; NORMAL HUMAN; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; UPREGULATION; WESTERN BLOTTING; CELL DEATH; CYTOLOGY; DRUG EFFECTS; GENE SILENCING; INTRACELLULAR SPACE; MESENCHYMAL STROMA CELL; METABOLISM; PH;

ADIPOGENESIS; BETA CATENIN; CATION TRANSPORT PROTEINS; CELL DEATH; CELL DIFFERENTIATION; GENE KNOCKDOWN TECHNIQUES; GUANIDINES; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR SPACE; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PHENOTYPE; RNA, SMALL INTERFERING; SODIUM-HYDROGEN ANTIPORTER; SULFONES; UMBILICAL CORD; UP-REGULATION;

EID: 84893171367     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356661     Document Type: Article

References (45)

1. Webb BA, Chimenti M, Jacobson MP, Barber DL: Dysregulated ph: A perfect storm for cancer progression. Nat Rev Cancer 2011;11:671-677.
2. Rich IN, Worthington-White D, Garden OA, Musk P: Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+/H+ exchanger. Blood 2000;95:1427-1434.
3. Slepkov ER, Rainey JK, Sykes BD, Fliegel L: Structural and functional analysis of the Na+/H+ exchanger. Biochem J 2007;401:623-633.
4. Malo ME, Fliegel L: Physiological role and regulation of the Na+/H+ exchanger. Can J Physiol Pharmacol 2006;84:1081-1095.
5. Counillon L, Pouyssegur J: The expanding family of eucaryotic Na+/H+ exchangers. J Biol Chem 2000;275:1-4.
6. Wakabayashi S, Shigekawa M, Pouyssegur J: Molecular physiology of vertebrate Na+/H+ exchangers. Physiol Rev 1997;77:51-74.
7. Reshkin SJ, Cardone RA, Harguindey S: Na+/H+ exchanger, pH regulation and cancer. Recent Pat Anti-cancer Drug Discov 2013;8:85-99.
8. Jin W, Li Q, Wang J, Chang G, Lin Y, Li H, Wang L, Gao W, Pang T: Na+/H+ exchanger 1 inhibition contributes to K562 leukaemic cell differentiation. Cell Biol Int 2012;36:739-745.
9. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A: Clarification of the nomenclature for MSC: The international society for cellular therapy position statement. Cytotherapy 2005;7:393-395.
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006;8:315-317.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
12. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
13. De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, Benhaim P, Hedrick MH, Fraser JK: Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 2003;89:267-270.
14. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H: In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem Biophys Res Commun 2005;330:1153-1161.
15. Covas DT, Siufi JL, Silva AR, Orellana MD: Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 2003;36:1179-1183.
16. Mihu CM, Rus Ciuca D, Soritau O, Susman S, Mihu D: Isolation and characterization of mesenchymal stem cells from the amniotic membrane. Rom J Morphol Embryol 2009;50:73-77.
17. Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Le AD: Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 2009;183:7787-7798.
18. Siepe M, Thomsen AR, Duerkopp N, Krause U, Forster K, Hezel P, Beyersdorf F, Schlensak C, Sudkamp NP, Bosse R, Niemeyer P: Human neonatal thymus-derived mesenchymal stromal cells: Characterization, differentiation, and immunomodulatory properties. Tissue Eng Part A 2009;15:1787-1796.
19. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X: Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 2006;30:681-687.
20. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T: Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-2529.
21. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396-2402.
22. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, Weichert A, Scholkens BA: Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995;29:260-268.
23. Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N, Stamp G, Bonnet D, Janes SM: Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007;25:1586-1594.
24. Gao W, Chang G, Wang J, Jin W, Wang L, Lin Y, Li H, Ma L, Li Q, Pang T: Inhibition of K562 leukemia angiogenesis and growth by selective Na+/H+ exchanger inhibitor cariporide through down-regulation of pro-angiogenesis factor VEGF. Leuk Res 2011;35:1506-1511.
25. Semina OV, Semenets TN, Zamulaeva IA, Selivanova EI, Iljina TP, Maliutina YV, Semin DY, Deigin VI, Saenko AS: Dipeptide gamma-d-glu-d-trp (thymodepressin) inhibits migration of CD34+ cells from the bone marrow into peripheral blood during tumor growth. Bull Exp Biol Med 2008;146:96-99.
26. Grinstein S, Woodside M, Sardet C, Pouyssegur J, Rotin D: Activation of the Na+/H+ antiporter during cell volume regulation. Evidence for a phosphorylation-independent mechanism. J Biol Chem 1992;267:23823-23828.
27. Grinstein S, Rotin D, Mason MJ: Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim Biophys Acta 1989;988:73-97.
28. Lu Y, Pang T, Wang J, Xiong D, Ma L, Li B, Li Q, Wakabayashi S: Down-regulation of p-glycoprotein expression by sustained intracellular acidification in K562/DOX cells. Biochem Biophys Res Commun 2008;377:441-446.
29. Puceat M: pHi regulatory ion transporters: An update on structure, regulation and cell function. Cell Mol Life Sci 1999;55:1216-1229.
30. Enerson BE, Drewes LR: Molecular features, regulation, and function of monocarboxylate transporters: Implications for drug delivery. J Pharm Sci 2003;92:1531-1544.
31. Halestrap AP, Price NT: The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999;343:281-299.
32. Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ: Vacuolar-type H+-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 1993;265:C1015-1029.
33. Nishi T, Forgac M: The vacuolar H+-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002;3:94-103.
34. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Rey JM, Garcia-Garcia A: V-ATPase inhibitors and implication in cancer treatment. Cancer Treat Rev 2009;35:707-713.
35. Fan CG, Zhang QJ, Zhou JR: Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 2011;7:195-207.
36. Schneider RK, Puellen A, Kramann R, Raupach K, Bornemann J, Knuechel R, Perez-Bouza A, Neuss S: The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials 2010;31:467-480.
37. Roodman GD: Novel targets for myeloma bone disease. Expert Opin Ther Targets 2008;12:1377-1387.
38. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr: The role of the wnt-signaling antagonist dkk1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003;349:2483-2494.
39. Westendorf JJ, Kahler RA, Schroeder TM: Wnt signaling in osteoblasts and bone diseases. Gene 2004;341:19-39.
40. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB: Canonical wnt signaling promotes osteogenesis by directly stimulating runx2 gene expression. J Biol Chem 2005;280:33132-33140.
41. Takewaki S, Kuro-o M, Hiroi Y, Yamazaki T, Noguchi T, Miyagishi A, Nakahara K, Aikawa M, Manabe I, Yazaki Y, et al.: Activation of Na+/H+ antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cell Cardiol 1995;27:729-742.
42. Mukhin YV, Garnovskaya MN, Ullian ME, Raymond JR: ERK is regulated by sodium-proton exchanger in rat aortic vascular smooth muscle cells. J Biol Chem 2004;279:1845-1852.
43. Chen S, Khan ZA, Karmazyn M, Chakrabarti S: Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy. Diabetes Metab Res Rev 2007;23:356-367.
44. Bikkavilli RK, Feigin ME, Malbon CC: p38 mitogen-activated protein kinase regulates canonical wnt-β-catenin signaling by inactivation of GSK3β. J Cell Sci 2008;121:3598-3607.
45. Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A, Vancheri C: TGF-β1 targets the GSK-3β/β- catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 2008;57:274-282.